Mechanotransduction, PROX1, and FOXC2 Cooperate to Control Connexin37 and Calcineurin during Lymphatic-Valve Formation

Developmental Cell

Volumn 22, Issue 2, 2012, Pages 430-445

  Sabine, Amélie ^a,b   Agalarov, Yan ^a,b   Maby ElHajjami, Hélène ^a,b   Jaquet, Muriel ^a,b   Hägerling, René ^c   Pollmann, Cathrin ^c   Bebber, Damien ^a,b   Pfenniger, Anna ^e   Miura, Naoyuki ^f   Dormond, Olivier ^a   Calmes, Jean Marie ^a   Adams, Ralf H ^c,d   Mäkinen, Taija ^g   Kiefer, Friedemann ^c   Kwak, Brenda R ^e   Petrova, Tatiana V ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EPFL   (Switzerland)

^c MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e UNIVERSITY OF GENEVA   (Switzerland)

^f HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALCINEURIN; CONNEXIN 37; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR PROX1; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVATION; HUMAN; LYMPH VESSEL; LYMPHANGIOGENESIS; MECHANOTRANSDUCTION; MODEL; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; SHEAR STRESS; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CALCINEURIN; CELL PROLIFERATION; CONNEXINS; EMBRYO, MAMMALIAN; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MECHANOTRANSDUCTION, CELLULAR; MICE; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84857026228     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2011.12.020     Document Type: Article

References (52)

1. Adamo L., Naveiras O., Wenzel P.L., McKinney-Freeman S., Mack P.J., Gracia-Sancho J., Suchy-Dicey A., Yoshimoto M., Lensch M.W., Yoder M.C., et al. Biomechanical forces promote embryonic haematopoiesis. Nature 2009, 459:1131-1135.
2. Bazigou E., Xie S., Chen C., Weston A., Miura N., Sorokin L., Adams R., Muro A.F., Sheppard D., Makinen T. Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev. Cell 2009, 17:175-186.
3. Bazigou E., Lyons O.T., Smith A., Venn G.E., Cope C., Brown N.A., Makinen T. Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J.Clin. Invest. 2011, 121:2984-2992.
4. Beis D., Bartman T., Jin S.W., Scott I.C., D'Amico L.A., Ober E.A., Verkade H., Frantsve J., Field H.A., Wehman A., et al. Genetic and cellular analyses of zebrafish atrioventricular cushion and valve development. Development 2005, 132:4193-4204.
5. Boon R.A., Horrevoets A.J. Key transcriptional regulators of the vasoprotective effects of shear stress. Hamostaseologie 2009, 29:39-40. 41-43.
6. Brice G., Mansour S., Bell R., Collin J.R., Child A.H., Brady A.F., Sarfarazi M., Burnand K.G., Jeffery S., Mortimer P., Murday V.A. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J.Med. Genet. 2002, 39:478-483.
7. Chang C.P., Neilson J.R., Bayle J.H., Gestwicki J.E., Kuo A., Stankunas K., Graef I.A., Crabtree G.R. A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis. Cell 2004, 118:649-663.
8. Chiu J.J., Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol. Rev. 2011, 91:327-387.
9. Claxton S., Kostourou V., Jadeja S., Chambon P., Hodivala-Dilke K., Fruttiger M. Efficient, inducible Cre-recombinase activation in vascular endothelium. Genesis 2008, 46:74-80.
10. Crabtree G.R., Olson E.N. NFAT signaling: choreographing the social lives of cells. Cell 2002, 109(Suppl):S67-S79.
11. Dixon J.B., Greiner S.T., Gashev A.A., Cote G.L., Moore J.E., Zawieja D.C. Lymph flow, shear stress, and lymphocyte velocity in rat mesenteric prenodal lymphatics. Microcirculation 2006, 13:597-610.
12. (2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 2001, 105:863-875.
13. Hagerling R., Pollmann C., Kremer L., Andresen V., Kiefer F. Intravital two-photon microscopy of lymphatic vessel development and function using a transgenic Prox1 promoter-directed mOrange2 reporter mouse. Biochem. Soc. Trans. 2011, 39:1674-1681.
14. Hahn C., Schwartz M.A. Mechanotransduction in vascular physiology and atherogenesis. Nat. Rev. Mol. Cell Biol. 2009, 10:53-62.
15. Hernández G.L., Volpert O.V., Iñiguez M.A., Lorenzo E., Martínez-Martínez S., Grau R., Fresno M., Redondo J.M. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated Tcells and cyclooxygenase 2. J.Exp. Med. 2001, 193:607-620.
16. Iida K., Koseki H., Kakinuma H., Kato N., Mizutani-Koseki Y., Ohuchi H., Yoshioka H., Noji S., Kawamura K., Kataoka Y., et al. Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development 1997, 124:4627-4638.
17. Johnson E.N., Lee Y.M., Sander T.L., Rabkin E., Schoen F.J., Kaushal S., Bischoff J. NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J.Biol. Chem. 2003, 278:1686-1692.
18. Kampmeier O.F. The genetic history of the valves in the lymphatic system of man. Am. J. Anat. 1928, 40:413-457.
19. Kampmeier O.F., Brich L.F. The origin and development of the venous valves, with particular reference to the saphenous district. Am. J. Anat. 1927, 38:451-499.
20. Kanady J.D., Dellinger M.T., Munger S.J., Witte M.H., Simon A.M. Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev. Biol. 2011, 354:253-266.
21. Karkkainen M.J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T.V., Jeltsch M., Jackson D.G., Talikka M., Rauvala H., et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 2004, 5:74-80.
22. Kulkarni R.M., Greenberg J.M., Akeson A.L. NFATc1 regulates lymphatic endothelial development. Mech. Dev. 2009, 126:350-365.
23. Kumai M., Nishii K., Nakamura K., Takeda N., Suzuki M., Shibata Y. Loss of connexin45 causes a cushion defect in early cardiogenesis. Development 2000, 127:3501-3512.
24. Lehr H.A., Leunig M., Menger M.D., Nolte D., Messmer K. Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am. J. Pathol. 1993, 143:1055-1062.
25. Mäkinen T., Adams R.H., Bailey J., Lu Q., Ziemiecki A., Alitalo K., Klein R., Wilkinson G.A. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 2005, 19:397-410.
26. May S.R., Stewart N.J., Chang W., Peterson A.S. A Titin mutation defines roles for circulation in endothelial morphogenesis. Dev. Biol. 2004, 270:31-46.
27. Mellor R.H., Brice G., Stanton A.W., French J., Smith A., Jeffery S., Levick J.R., Burnand K.G., Mortimer P.S. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 2007, 115:1912-1920. Lymphoedema Research Consortium.
28. Ng C.P., Helm C.L., Swartz M.A. Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis invitro. Microvasc. Res. 2004, 68:258-264.
29. Norrmén C., Ivanov K.I., Cheng J., Zangger N., Delorenzi M., Jaquet M., Miura N., Puolakkainen P., Horsley V., Hu J., et al. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J.Cell Biol. 2009, 185:439-457.
30. Petrova T.V., Mäkinen T., Mäkelä T.P., Saarela J., Virtanen I., Ferrell R.E., Finegold D.N., Kerjaschki D., Ylä-Herttuala S., Alitalo K. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 2002, 21:4593-4599.
31. Petrova T.V., Karpanen T., Norrmén C., Mellor R., Tamakoshi T., Finegold D., Ferrell R., Kerjaschki D., Mortimer P., Ylä-Herttuala S., et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 2004, 10:974-981.
32. Ringelmann B., Röder C., Hallmann R., Maley M., Davies M., Grounds M., Sorokin L. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice. Exp. Cell Res. 1999, 246:165-182.
33. Rockson S.G. Secondary lymphedema: is it a primary disease?. Lymphat. Res. Biol. 2008, 6:63-64.
34. Saaristo A., Veikkola T., Tammela T., Enholm B., Karkkainen M.J., Pajusola K., Bueler H., Ylä-Herttuala S., Alitalo K. Lymphangiogenic gene therapy with minimal blood vascular side effects. J.Exp. Med. 2002, 196:719-730.
35. Schweighofer B., Testori J., Sturtzel C., Sattler S., Mayer H., Wagner O., Bilban M., Hofer E. The VEGF-induced transcriptional response comprises gene clusters at the crossroad of angiogenesis and inflammation. Thromb. Haemost. 2009, 102:544-554.
36. Simon A.M., McWhorter A.R. Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev. Biol. 2002, 251:206-220.
37. Simon A.M., Goodenough D.A., Li E., Paul D.L. Female infertility in mice lacking connexin 37. Nature 1997, 385:525-529.
38. Srinivasan R.S., Oliver G. Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves. Genes Dev. 2011, 25:2187-2197.
39. Tarbell J.M., Ebong E.E. The endothelial glycocalyx: a mechano-sensor and -transducer. Sci. Signal. 2008, 1:pt8.
40. Tzima E., Irani-Tehrani M., Kiosses W.B., Dejana E., Schultz D.A., Engelhardt B., Cao G., DeLisser H., Schwartz M.A. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 2005, 437:426-431.
41. Vermot J., Forouhar A.S., Liebling M., Wu D., Plummer D., Gharib M., Fraser S.E. Reversing blood flows act through klf2a to ensure normal valvulogenesis in the developing heart. PLoS Biol. 2009, 7:e1000246.
42. Wang Y., Nakayama M., Pitulescu M.E., Schmidt T.S., Bochenek M.L., Sakakibara A., Adams S., Davy A., Deutsch U., Lüthi U., et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 2010, 465:483-486.
43. Wei C.J., Xu X., Lo C.W. Connexins and cell signaling in development and disease. Annu. Rev. Cell Dev. Biol. 2004, 20:811-838.
44. Wigle J.T., Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999, 98:769-778.
45. Wong C.W., Christen T., Roth I., Chadjichristos C.E., Derouette J.P., Foglia B.F., Chanson M., Goodenough D.A., Kwak B.R. Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat. Med. 2006, 12:950-954.
46. Wu H., Peisley A., Graef I.A., Crabtree G.R. NFAT signaling and the invention of vertebrates. Trends Cell Biol. 2007, 17:251-260.
47. Xu Y., Yuan L., Mak J., Pardanaud L., Caunt M., Kasman I., Larrivée B., Del Toro R., Suchting S., Medvinsky A., et al. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J.Cell Biol. 2010, 188:115-130.
48. Yoshimatsu Y., Yamazaki T., Mihira H., Itoh T., Suehiro J., Yuki K., Harada K., Morikawa M., Iwata C., Minami T., et al. Ets family members induce lymphangiogenesis through physical and functional interaction with Prox1. J.Cell Sci. 2011, 124:2753-2762.
49. Zaichuk T.A., Shroff E.H., Emmanuel R., Filleur S., Nelius T., Volpert O.V. Nuclear factor of activated Tcells balances angiogenesis activation and inhibition. J.Exp. Med. 2004, 199:1513-1522.
50. Zawieja D.C. Contractile physiology of lymphatics. Lymphat. Res. Biol. 2009, 7:87-96.
51. Zeini M., Hang C.T., Lehrer-Graiwer J., Dao T., Zhou B., Chang C.P. Spatial and temporal regulation of coronary vessel formation by calcineurin-NFAT signaling. Development 2009, 136:3335-3345.
52. Zeng H., Chattarji S., Barbarosie M., Rondi-Reig L., Philpot B.D., Miyakawa T., Bear M.F., Tonegawa S. Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 2001, 107:617-629.